Global /China /Healthcare /Medical Care Facilities /9960

Kindstar Globalgene Technology, Inc.

9960

• SHEK: 9960 • Delayed

1.16HKD 0%

0.1480 USD

As of 6 June 2026, Kindstar Globalgene Technology, Inc. has a market cap of $147.62M USD, ranking #22976 globally and #5824 in China. It ranks #2070 in the Healthcare sector, and #244 in the Medical Care Facilities industry.

Global Rank

22976

Country Rank

5824

Sector Rank

2070

Industry Rank

244

Key Stats

Market Cap

$147.62MUSD

1.16B HKD

Enterprise Value

-$13.26MUSD

-103.88M HKD

Revenue (TTM)

$132.59MUSD

1.04B HKD

EBITDA (TTM)

-$12.79MUSD

-100.23M HKD

Net Income (TTM)

-$8.34MUSD

-65.37M HKD

EBITDA Margin

-9.6%

Profit Margin

-6.3%

PS Ratio

1.1

PB Ratio

0.4

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Medical Care Facilities

CEO

Shiang Huang open_in_new

Employees

3,100

Founded

2003

Website

kindstar.com.cn open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0%	-1.9%	6.4%	-4.9%	-15%	3.6%	-14%	-34%	-89%

News

Markets

Exchange	Ticker	Price	Quotes
Hong Kong Stock Exchange (SHEK / HKEX) MIC: XHKG PRIMARY	9960 康圣环球基因技术有限公司 ISIN: KYG5262E1044 Shares Out.: Shares Outstanding: 997.126M¹ Shares Float: 501.298M² TV: TradingView: HKEX: 9960 SA: Stock Analysis: HKG: 9960 YF: Yahoo Finance: 9960.HK GF: Google Finance: HKG: 9960 BA: Barron's: 9960 MS: Morningstar: XHKG: 09960	1.16 HKD	TV: TradingView: HKEX: 9960 SA: Stock Analysis: HKG: 9960 YF: Yahoo Finance: 9960.HK GF: Google Finance: HKG: 9960 BA: Barron's: 9960 MS: Morningstar: XHKG: 09960

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Kindstar Globalgene Technology, Inc.

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China. The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases. It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases. The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories. The company was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.

Similar Companies

Industry: Medical Care Facilities (China)

Name	Market Cap (USD) diff.	PE	Country
Aier Eye Hospital Group Co., Ltd. SHE: 300015	$15.03B 101.77B CNY 10K%	30.1	China
Meinian Onehealth Healthcare Holdings Co., Ltd. SHE: 002044	$3.02B 20.46B CNY 2K%	75.1	China
Ping An Healthcare and Technology Company Ltd. SHEK: 1833	$2.94B 23.07B HKD 2K%	54.2	China
Topchoice Medical Co., Inc. SSE: 600763	$2.86B 19.35B CNY 2K%	38.6	China
Sanbo Hospital Management Group Ltd. SHE: 301293	$1.92B 12.97B CNY 1K%	218.8	China
Guangzhou Kingmed Diagnostics Group Co., Ltd. SSE: 603882	$1.87B 12.65B CNY 1K%	-	China

Industry: Medical Care Facilities (Global)

Name	Market Cap (USD) diff.	PE	Country
International Holding Company PJSC ADX: IHC	$232.18B 852.82B AED 157K%	44.1	United Arab Emirates
HCA Healthcare, Inc. NYSE: HCA	$96.73B 65K%	14.9	United States
Fresenius SE & Co. KGaA XETRA: FRE	$26.68B 22.97B EUR 18K%	15.0	Germany
Koninklijke Philips N.V. AMS: PHIA	$25.58B 22.02B EUR 17K%	24.9	Netherlands
Dr. Sulaiman Al Habib Medical Services Group Co. TADAWUL: 4013	$22.48B 84.42B SAR 15K%	35.2	Saudi Arabia
Labcorp Holdings Inc. NYSE: LH	$21.13B 14K%	24.6	United States

chevron_leftBack